Clinical Trial Update: Value of [68Ga]Ga-PSMA-11 PET/MRI in the Assessment of Liver Cirrhosis

View source ↗

Summary

Clinical trial evaluating the utility of [68Ga]Ga-PSMA-11 PET/MRI for assessing liver cirrhosis and related conditions is currently recruiting at Massachusetts …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma
• Liver Cirrhosis
• Portal Hypertension

Drugs mentioned

• [68Ga]Ga-PSMA-11

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Liver Cirrhosis, Hepatic Cell Carcinoma | Status: RECRUITING